Pharmacological treatment for attention deficit hyperactivity disorder: functional outcomes in children and adolescents from non-Western countries

Murat Altin, Ahmed A El-Shafei, Maria Yu, Durisala Desaiah, Tamas Treuer, Nikolay Zavadenko, Hong Yun Gao

Article Type

Original Research

Published

This prospective, observational, non-interventional study conducted in six non-Western countries concludes that after 12 months of treatment, clinical and functional outcomes were improved in children and adolescents with attention deficit hyperactivity disorder (ADHD) who initiated and remained on their prescribed pharmacological monotherapy.

Read more

Efficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentary

Susan G Ball, Durisala Desaiah, Qi Zhang, Michael E Thase, David G S Perahia

Article Type

Review

Published

Major depressive disorder (MDD) is a significant public health concern and challenges health care providers to intervene with appropriate treatment. This review provides evidence that duloxetine 60 mg QD is effective for the treatment of adult patients with MDD in the short- and long-term phases of treatment. Duloxetine 60 mg QD also represents a viable choice of treatment for those patients with painful physical symptoms associated with MDD.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.